Alkem Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

23.91

23.91

23.91

23.91

23.91

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

9,325.94

8,719.75

7,601.84

6,256.53

5,441.30

Loan funds

Secured loans

1,125.89

2,245.52

1,339.16

1,209.38

502.96

Unsecured loans

-

-

-

-

-

Total

10,475.74

10,989.18

8,964.91

7,489.82

5,968.17

Uses of funds

Fixed assets

Gross block

2,745.15

2,672.09

2,366.72

2,269.67

1,929.99

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

920.06

790.02

608.36

432.91

323.61

Net block

1,825.09

1,882.07

1,758.36

1,836.76

1,606.38

Capital work-in-progress

228.75

232.45

323.26

313.66

381.59

Investments

3,005.55

2,528.61

2,152.38

1,956.04

1,695.60

Net current assets

Current assets, loans & advances

7,671.83

8,526.04

6,538.73

4,999.37

3,608.58

Less : current liabilities & provisions

2,255.48

2,179.99

1,807.82

1,616.01

1,323.98

Total net current assets

5,416.35

6,346.05

4,730.91

3,383.36

2,284.60

Miscellaneous expenses not written

-

-

-

-

-

Total

10,475.74

10,989.18

8,964.91

7,489.82

5,968.17

Notes:

Book value of unquoted investments

2,782.40

235.16

221.98

179.26

240.42

Market value of quoted investments

223.15

-

-

-

-

Contingent liabilities

314.71

359.22

376.65

329.70

406.92

Number of equity sharesoutstanding (Lacs)

1195.65

1195.65

1195.65

1195.65

1195.65